НЕЙРОПРОТЕКТИВНАЯ ТЕРАПЯ ХРОНИЧЕСКОЙ ИШЕМИИ ГОЛОВНОГО МОЗГА (30-35)

Список литературы: 1. Squartsova V.I., Evselman M.A./ Ischemic Stroke; Orel. 2006: 4. 2. Squartsova V. I. Reduction of morbidity, mortality and disability from strokes in the Russian Federation. Journal of neurology and psychiatry named after S. S. Korsakov (Special issue "Stroke"); 2007: 2531. 3. Gulaeva N.V. Interplay between Brain BDNF and Glutamatergic Systems: A Brief State of the Evidence and Association with the Pathogenesis of Depression. Biochemistry (Moscow); 2017:82 (3): 441-448. 4. Sholomov I. I., E. B. Lutoshkina. Dynamics of cognitive functions in assessing the use of Cortexin in patients with cerebrovascular pathology / / Terra Medica nova. - 2003. No. 1: 15-16. 5. Skoromeze A. A., Dyakonov M. M. Cortexin is a five-year experience of domestic neurology. SPb.: Science; 2005: 208. 6. Alexandrova N.A. // The effect of prolonged neurometabolic treatment on the dynamics of clinical, neurological and neuropsychological changes in patients with ischemic stroke. Abstract; 2007. 7. Boyko A. N., Batysheva T. T., Kostenko E. V., Zaitsev K. A. Neuroprotectors in the complex therapy of patients with chronic cerebral circulatory insufficiency in the conditions of the clinical neuropsychology of the CAO of Moscow."Rmzh" No. 11 of 12.05.2009: 784 8. Tanashyan M. M., Barkhatov D. Yu., Glotova N. A., Konovalov R. N., Fedin P. A., Guriev M. N., Ketlinskaya O. S. Effectiveness of neuroprotection in patients with chronic cerebrovascular diseases. Journal Bulletin of the Russian military medical Academy; 2011: 181-187. 9. M.A. Asselman, N. A. Alexandrovа. Cognitive impairment in patients with ischemic stroke and their correction. Journal of neurology and psychiatry. S. S. Korsakov; 2013;113(10): 36-39. 10. Mashin V.V., Belova L.A., Chaplanova O.I., Khusnullina A.F., Manasyan A.M. An open-label clinical trial of cortexin for discirculatory encephalopathy. Journal of Neurology and Psychiatry. S.S. Korsakova. 2014; 114 (9): 49-52. 11. V. N. Tsygan, M. M. Bogoslovsky, A.V. Mirolyubov. Electroencephalography / Acad. - St. Petersburg: Nauka; 2008:187 . 12. Rudenko A. O., Eltysheva T. E., Diakonov M. M. Influence of amino acid spectrum of peptide organopreparations on pharmacotherapy efficiency. Bulletin of the Russian military medical Academy. 2017; 1(57): 129-136. 13. Markova H, Andel R, Stepankova H, Kopecek M, Nikolai T, Hort J, Thomas-Antérion C, Vyhnalek M. Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms. J Alzheimer’s Dis. 2017;59(3):871-881. 14. Archer HA, Newson MA, Coulthard EJ. Subjective Memory Complaints: Symptoms and Outcome in Different Research Settings. J Alzheimer’s Dis. 2015;48(1):109-114. 15. Staals J, Booth T, Morris Z, Bastin ME, Gow AJ, Corley J, Redmond P, Starr JM, Deary IJ, Wardlaw JM. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 36(10): 2806-2811. 16. Fundamentals of neuropsychology. Moscow: Academia; 2003: 384. 17. Damulin I. V. Alzheimer's Disease and vascular dementia. Edited By N. N. Yakhno.Moscow, 2002; 85. 18. Skorokhodov A, P., Belinskaya V. V. Cortexin in conservative treatment of hemorrhagic stroke / / Proceedings of the jubilee scientific and practical conference "Actual issues of restorative medicine in the clinic and sanatorium institutions". Voronezh, 2002: 96-98.